Summit Therapeutics
SMMT
#2225
Rank
โ‚น784.83 B
Marketcap
โ‚น981.33
Share price
-1.59%
Change (1 day)
-34.08%
Change (1 year)

EPS for Summit Therapeutics (SMMT)

EPS in 2026 (TTM): -โ‚น99.99

According to Summit Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น100.00. In 2025 the company made an earnings per share (EPS) of -โ‚น135.52.

EPS history for Summit Therapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น99.99-26.22%
2025-โ‚น135.52
2021-โ‚น89.7226.32%
2020-โ‚น71.03
2018-โ‚น4.06-84.63%
2017-โ‚น26.39-40.59%
2016-โ‚น44.426.54%
2015-โ‚น41.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sarepta Therapeutics
SRPT
-โ‚น245.80 145.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
โ‚น1,295-1,395.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
-โ‚น96.26-3.74%๐Ÿ‡บ๐Ÿ‡ธ USA